Characterization of succinate dehydrogenase and α-glycerophosphate dehydrogenase in pancreatic islets

Abstract

Succinate dehydrogenase activities in homogenates of rat and ob ob mouse pancreatic islets were only 13% of the activities in homogenates of liver and were also several times lower than in homogenates of pancreatic acinar tissue. This indicates that the content of mitochondria in pancreatic islet cells is very low. The very low activity of succinate dehydrogenase is in agreement with the low mitochondrial volume in the cytoplasmic ground substance of pancreatic islet cells as observed in morphometric studies. This may represent the poor equipment of pancreatic islet cells with electron transport chains and thus provide a regulatory role for the generation of reducing equivalents and chemical energy for the regulation of insulin secretion. The activities of succinate dehydrogenase in tissue homogenates of pancreatic islets, pancreatic acinar tissue, and liver were significantly inhibited by malonate and diazoxide but not by glucose, mannoheptulose, streptozotocin, or verapamil. Tolbutamide inhibited only pancreatic islet succinate dehydrogenase significantly, providing evidence for a different behavior of pancreatic islet cell mitochondria. Therefore diazoxide and tolbutamide may affect pancreatic islet function through their effects on succinate dehydrogenase activity. The activities of α-glycerophosphate dehydrogenase in homogenates of pancreatic islets and liver from rats and ob ob mice were in the same range, while activities in homogenates of pancreatic acinar tissue were lower. None of the test agents affected α-glycerophosphate dehydrogenase activity. Thus the results provide no support for the recent contention that α-glycerophosphate dehydrogenase activity may be critical for the regulation of insulin secretion.